Novartis AG
DUS:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
DUS:NOT
|
CH |
|
Rexford Industrial Realty Inc
NYSE:REXR
|
US |
|
Poste Italiane SpA
F:7PI
|
IT |
|
Novatek PAO
MOEX:NVTK
|
RU |
|
Guillemot Corporation SA
PAR:GUI
|
FR |
|
Jabil Inc
NYSE:JBL
|
US |
|
C
|
Central Garden & Pet Co
NASDAQ:CENTA
|
US |
|
Delta Electronics Thailand PCL
SET:DELTA
|
TH |
|
Clorox Co
NYSE:CLX
|
US |
|
T
|
Targa Resources Corp
F:TAR
|
US |
|
M
|
Masco Corp
XMUN:MSQ
|
US |
|
Intercontinental Exchange Inc
NYSE:ICE
|
US |
|
C
|
Cementir Holding NV
XBER:3PC
|
IT |
|
M
|
Minor International PCL
SET:MINT
|
TH |
|
A
|
Abbott Laboratories
SIX:ABT
|
US |
|
C
|
CME Group Inc
SWB:MX4A
|
US |
|
B
|
BRP Inc
NASDAQ:DOOO
|
CA |
|
A
|
Autogrill SpA
MIL:AGL
|
IT |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 136.15 EUR with a low forecast of 104.28 EUR and a high forecast of 159.76 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
136.15
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 136.15 EUR with a low forecast of 104.28 EUR and a high forecast of 159.76 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
